Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Eromycin
2. Erythromycin Propionate Dodecyl Sulfate
3. Erythromycin Propionate Lauryl Sulfate
4. Erythromycin Propionate Monododecyl Sulfate
5. Estolate, Erythromycin
6. Ilosone
7. Lauromicina
1. Ilosone
2. 3521-62-8
3. Lauromicina
4. Erythromycin Propionate Lauryl Sulfate
5. Marcoeritrex
6. Stellamicina
7. Eritroger
8. Estomicina
9. Roxomicina
10. Neo-erycinum
11. Erythromycin Estorate
12. Pels
13. Eromycin
14. Biomicron
15. Eriscel
16. Propionylerythromycin Lauryl Sulfate
17. Erythromycin (as Estolate)
18. Erythromycin 2'-propionate Dodecyl Sulfate (salt)
19. Xrj2p631hp
20. Erythromycin, 2'-propanoate, Dodecyl Sulfate (salt)
21. Prospiocine
22. Erytrarco
23. Lauryl Sulfate Propionyl Erythromycin Ester
24. Chebi:4846
25. Ery-toxinal Dodecylsulfate
26. Erythromycinestolate
27. Erythromycin Propionate, Compound With Dodecyl Sulfate
28. Nsc-263364
29. Lubomycine B
30. Erythromycin Estorate (jan)
31. Erythromycin Propionate Dodecylsulfate (salt)
32. Erythromycin 5-(3-propionate) Dodecyl Sulfate
33. Erythromycin Estorate [jan]
34. Erythromycine Estolate
35. Erythromycin Propionyl Laurylsulfate
36. Erythromycin Propionate, Compd. With Dodecyl Sulfate
37. Unii-xrj2p631hp
38. Einecs 222-532-4
39. Ilosone (tn)
40. Nsc 263364
41. Erythromycin Estolate [usan:usp:ban:jan]
42. Schembl3331
43. Dsstox_cid_17224
44. Dsstox_rid_79309
45. Dsstox_gsid_37224
46. Erythromycin Estolate (usp)
47. Spectrum1501176
48. Chembl2218877
49. Dtxsid1037224
50. Erythromycin, 2'-propionate, Monododecyl Sulfate (salt)
51. Bdbm31688
52. Hms500a11
53. Erythromycin Estolate [mi]
54. Hms1921n13
55. Hms2092j15
56. Pharmakon1600-01501176
57. Erythromycin, Propionate (ester), Compd. With Monododecyl Sulfate
58. Hy-n7121
59. Propionic Acid, 2'-ester With Erythromycin, Dodecyl Sulfate Salt
60. Erythromycin Estolate [usan]
61. Tox21_302229
62. Ccg-38968
63. Erythromycin Estolate [vandf]
64. Lmpk04000015
65. Mfcd00084691
66. Nsc757880
67. S5532
68. Erythromycin Estolate [mart.]
69. Monopropionylerythromycin Laurylsulfate
70. Akos015896121
71. Erythromycin Estolate [usp-rs]
72. Erythromycin Estolate [who-dd]
73. Nsc-757880
74. Sulfuric Acid, Monododecyl Ester, Compd. With Erythromycin 2'-propionate (1:1)
75. Ncgc00180881-01
76. Ncgc00180881-02
77. Ncgc00255571-01
78. Cas-3521-62-8
79. Erythromycin Estolate [orange Book]
80. Erythromycin 2''-propionate Dodecyl Sulfate
81. Erythromycin Estolate [ep Monograph]
82. Propionyl Erythromycin Lauryl Sulfate
83. Cs-0031228
84. Erythromycin Estolate [usp Monograph]
85. Erythromycin Lauryl Sulfate, Propionyl
86. C08031
87. D00851
88. D70256
89. 521e628
90. Sr-05000002085
91. Ilosone Sulfa Component Erythromycin Estolate
92. Q-201066
93. Sr-05000002085-1
94. Q27106503
95. Erythromycin Estolate Component Of Ilosone Sulfa
96. Erythromycin 2'-propionate Dodecyl Sulfate (salt).
97. Erythromycin 2'-propionate Dodecyl Sulphate (salt).
98. Propionic Acid, 2'-ester With Erythromycin, Dodecyl Sulfate
99. Erythromycin, 2'-propanoate, Dodecyl Sulphate (salt)
100. Erythromycin, Propionate (ester), Compd. With Monododecyl Sulfate (1:1)
101. Sulfuric Acid, Monododecyl Ester, Compd. With Erythromycin 2'-propanoate (1:1)
102. (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-4-(2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-2-o-propanoyl-beta-d-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione Dodecyl Hydrogen Sulfate
103. [(2s,3r,4s,6r)-4-(dimethylamino)-2-[[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] Propanoate;dodecyl Hydrogen Sulfate
Molecular Weight | 1056.4 g/mol |
---|---|
Molecular Formula | C52H97NO18S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 22 |
Exact Mass | 1055.64263642 g/mol |
Monoisotopic Mass | 1055.64263642 g/mol |
Topological Polar Surface Area | 272 Ų |
Heavy Atom Count | 72 |
Formal Charge | 0 |
Complexity | 1550 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34798
Submission : 2020-07-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27889
Submission : 2013-12-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2198
Submission : 1973-12-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13204
Submission : 1998-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13331
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13333
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13676
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8560
Submission : 1990-03-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13458
Submission : 1998-09-01
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?